Macrophage correlates with immunophenotype and predicts anti-PD-L1 response of urothelial cancer

Immune-checkpoint blockades (ICBs) have been routinely implemented to treat metastatic urothelial cancer (mUC), whereas robust biomarkers are urgently warranted. Herein, we explored latent promising biomarkers based on 348 pretreatment mUC samples from IMvigor210. Methods: The genome, transcriptome,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Dongqiang, Ye, Zilan, Wu, Jiani, Zhou, Rui, Fan, Xinxiang, Wang, Gaofeng, Huang, Yiqiang, Wu, Jianhua, Sun, Huiying, Wang, Miaohong, Bin, Jianping, Liao, Yulin, Li, Nailin, Shi, Min, Liao, Wangjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295060/
https://www.ncbi.nlm.nih.gov/pubmed/32550918
http://dx.doi.org/10.7150/thno.46176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295060/
https://www.ncbi.nlm.nih.gov/pubmed/32550918
http://dx.doi.org/10.7150/thno.46176

Ejemplares similares